Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Fanconi Anemia 1

Interventions

Cyclophosphamide 6fludarabine phosphate 5Antilymphocyte Serum 5Busulfan 4Methylprednisolone 3Melphalan 3Filgrastim 3thymoglobulin 2fludarabine 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Granulocyte Colony-Stimulating Factor 2Cord Blood Stem Cell Transplantation 2AP 1903 reagent 2sargramostim 1Whole-Body Irradiation 1Tacrolimus 1Stem Cell Transplantation 1Reverse Transcriptase Polymerase Chain Reaction 1Polymerase Chain Reaction 1Microarray Analysis 1Immunoenzyme Techniques 1Electrophoresis, Polyacrylamide Gel 1Cyclosporine 1Chromatography, High Pressure Liquid 1Chromatography 1Blotting, Western 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fanconi Anemia × Chromatography × Myeloid × Clear all
NCT00900055 2022-07-05

Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma

OHSU Knight Cancer Institute

Completed
213 enrolled
Classical hematologyMyeloidPlasma cell

Fanconi Anemia, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡